Crop Life Science Limited (NSE:CLSL)

Crop Life Science Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	34.82	9.48	23.92	3.79	20.68
Short-Term Investments	-	-	2.7	-	-
Cash & Short-Term Investments	34.82	9.48	26.62	3.79	20.68
Cash Growth	267.35%	-64.39%	602.51%	-81.68%	-33.05%
Accounts Receivable	741.45	692.92	772.62	325.56	368.63
Other Receivables	-	0.06	-	0.06	-
Receivables	741.45	695.85	772.62	326.2	368.89
Inventory	705.56	488.94	398.18	261.88	222.61
Prepaid Expenses	-	6.43	-	70.85	21.25
Other Current Assets	284.76	220.29	202.43	192.81	180.89
Total Current Assets	1,767	1,421	1,400	855.52	814.32
Property, Plant & Equipment	275.68	354.48	363.03	152.43	123.07
Long-Term Investments	6.39	6.01	-	-	-
Goodwill	19.61	19.61	19.61	-	-
Other Intangible Assets	4.56	6.11	8.29	3.41	3.73
Long-Term Deferred Tax Assets	-	-	-	-	0.23
Other Long-Term Assets	6.7	9.86	7.9	4.5	4.42
Total Assets	2,080	1,817	1,799	1,016	945.78

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	521.26	415.82	527.44	199.89	222.29
Accrued Expenses	-	34.96	37.76	48.76	41.66
Short-Term Debt	-	350.18	242.55	167.16	174.82
Current Portion of Long-Term Debt	511.99	28	13.42	37.73	17.72
Current Portion of Leases	9.03	9.89	7.81	7.57	2.18
Current Income Taxes Payable	4.87	0.84	2.73	-	1.5
Other Current Liabilities	90.77	88.23	97.23	86.26	92.83
Total Current Liabilities	1,138	927.91	928.94	547.37	553.01
Long-Term Debt	24.07	27.75	56.79	2.23	16.76
Long-Term Leases	20.58	27.33	33.45	0.62	3.79
Pension & Post-Retirement Benefits	-	8.22	5.3	4.84	12.04
Long-Term Deferred Tax Liabilities	5.98	9.08	12.83	-	-
Other Long-Term Liabilities	10.97	3.26	2.23	55.26	-
Total Liabilities	1,200	1,004	1,040	610.32	585.59

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	171.4	171.4	171.4	120	120
Retained Earnings	-	601.85	542.93	283.04	242.32
Comprehensive Income & Other	671.06	1.3	2.93	2.51	-2.14
Total Common Equity	842.46	774.54	717.26	405.54	360.19
Minority Interest	37.55	38.96	41.86	-	-
Shareholders' Equity	880.01	813.5	759.12	405.54	360.19
Total Liabilities & Equity	2,080	1,817	1,799	1,016	945.78

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	565.67	443.15	354.03	215.31	215.27
Net Cash (Debt)	-530.84	-433.67	-327.41	-211.52	-194.59
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-30.32	-25.30	-19.10	-17.63	-16.22
Filing Date Shares Outstanding	21.77	17.14	17.14	12.06	12
Total Common Shares Outstanding	21.77	17.14	17.14	12.06	12
Working Capital	628.66	493.07	470.9	308.15	261.32
Book Value Per Share	38.70	45.19	41.85	33.61	30.02
Tangible Book Value	818.29	748.82	689.36	402.13	356.46
Tangible Book Value Per Share	37.59	43.69	40.22	33.33	29.70
Land	-	86.71	85.73	-	5.6
Buildings	-	169.15	162.73	-	56.94
Machinery	-	204.53	179.71	-	76.22
Construction In Progress	-	-	-	-	14.48

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error